Skip to content

Clinical study on Dual-Target rTMS for executive dysfunction and activities of daily living after stroke

Clinical study on Dual-Target rTMS for executive dysfunction and activities of daily living after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110350
Enrollment
Unknown
Registered
2025-10-13
Start date
2025-10-16
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post stroke executive dysfunction

Interventions

Group B:Real L-DLPFC+fake M1 stimulation
Group A:Real L-DLPFC+real M1 stimulation

Sponsors

Longyan First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: Meets the 2019 diagnostic criteria for cerebrovascular diseases of the Chinese Medical Association 2: First onset, unilateral cerebral hemisphere stroke, all confirmed by imaging (CT or MRI); 3: Age range from 18 to 75 years old, stroke duration from 2 weeks to 6 months, stable condition 4: Conduct Montreal Cognitive Assessment (MoCA) and Frontal Assessment Battery (FAB) assessments, with MoCA<26 and FAB<12 indicating executive dysfunction 5: No aphasia and able to complete cognitive scale assessment 6: Right-handed 7: The patient provides informed consent for the study and signs the informed consent form

Exclusion criteria

Exclusion criteria: 1: Patients with metal implants in the skull or implanted electronic devices (such as pacemakers) in the body 2: Patients with skull defects 3: Patients with a history of epilepsy, mental illness, malignant tumors, etc 4: Patients with severe organ dysfunction or unstable vital signs 5: There are serious visual and hearing impairments, such as color blindness, deafness, etc 6: Patients with cognitive impairment caused by other diseases such as traumatic brain injury, Parkinson's disease, etc 7: Has severe aphasia

Design outcomes

Primary

MeasureTime frame
modified Barthe lindex,MBI;montreal cognitive assessment, MoCA;Concentrations of oxygenated hemoglobin and deoxyhemoglobin in the cerebral cortex ;frontal assessment battery,FAB;

Secondary

MeasureTime frame
Fugl-Meyer assessment-upper extremity,FMA-UE;stroop color?wordtest, SCWT;digitspantest,DST;

Countries

China

Contacts

Public ContactMengting Lai

Longyan First Affiliated Hospital of Fujian Medical University

1017473776@qq.com+86 147 5915 5004

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026